Biomea Research Development from 2010 to 2026

BMEA Stock  USD 1.18  0.08  6.35%   
Biomea Fusion's Research Development is increasing over the years with slightly volatile fluctuation. Overall, Research Development is expected to go to about 142.6 M this year. From 2010 to 2026 Biomea Fusion Research Development quarterly data regression line had arithmetic mean of  35,548,023 and r-squared of  0.69. View All Fundamentals
 
Research Development  
First Reported
2020-03-31
Previous Quarter
16.6 M
Current Value
14.4 M
Quarterly Volatility
10.8 M
 
Covid
 
Interest Hikes
Check Biomea Fusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomea Fusion's main balance sheet or income statement drivers, such as Net Interest Income of 6.8 M, Interest Income of 6.8 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.57. Biomea financial statements analysis is a perfect complement when working with Biomea Fusion Valuation or Volatility modules.
  
Build AI portfolio with Biomea Stock
Check out the analysis of Biomea Fusion Correlation against competitors.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.

Latest Biomea Fusion's Research Development Growth Pattern

Below is the plot of the Research Development of Biomea Fusion over the last few years. It is Biomea Fusion's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biomea Fusion's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Biomea Research Development Regression Statistics

Arithmetic Mean35,548,023
Geometric Mean5,481,695
Coefficient Of Variation151.64
Mean Deviation45,175,209
Median1,092,000
Standard Deviation53,904,926
Sample Variance2905.7T
Range141.5M
R-Value0.83
Mean Square Error962.4T
R-Squared0.69
Significance0.000037
Slope8,863,940
Total Sum of Squares46491.9T

Biomea Research Development History

2026142.6 M
2025135.8 M
2024118.1 M
2023102.5 M
202262.7 M
202128 M
20203.7 M

About Biomea Fusion Financial Statements

Biomea Fusion stakeholders use historical fundamental indicators, such as Biomea Fusion's Research Development, to determine how well the company is positioned to perform in the future. Although Biomea Fusion investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomea Fusion's assets and liabilities are reflected in the revenues and expenses on Biomea Fusion's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomea Fusion. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development135.8 M142.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:
Check out the analysis of Biomea Fusion Correlation against competitors.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. Projected growth potential of Biomea fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Biomea Fusion assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(2.25)
Return On Assets
(0.75)
Return On Equity
(2.09)
Investors evaluate Biomea Fusion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Biomea Fusion's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Biomea Fusion's market price to deviate significantly from intrinsic value.
It's important to distinguish between Biomea Fusion's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomea Fusion should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Biomea Fusion's market price signifies the transaction level at which participants voluntarily complete trades.